Our Guide to Pre-Approval Access to Drugs For Both Doctors & Patients
By ALISON-BATEMAN HOUSE In April 2016, I published guidance, in the form of a mock case study, on how to access a drug before it has been approved by the FDA—wh...
By ALISON-BATEMAN HOUSE In April 2016, I published guidance, in the form of a mock case study, on how to access a drug before it has been approved by the FDA—wh...
By SABAH PERVEZ Bright ideas are nothing without those who enable action. For every bright idea in the digital health space, developers are needed to turn that...
By NIRAN AL-AGBA, MD There is a grassroots movement, 4300 strong, known as “Save Our Hospital” gaining notoriety in Albert Lea, Minnesota. This story is sympto...
By RICHARD DUSZAK, MD The online membership forum of the Society of Interventional Radiology (SIR) blew up this week in response to an email announcement by ...
By JAMES DOULGERIS, MD Kip Sullivan posted an op-ed in “The Health Care Blog,” “On the Ethics of Accountable Care Research,” on August 25, 2017. Mr. Sullivan’s ...
By JASON CHUNG Two months ago, I wrote about the potential impact of the Amazon purchase of Whole Foods on grocery prices. Both here and in the Boston Globe,...
By ALEX EPSTEIN As if 100+ deaths on U.S. highways every day isn’t horrific enough, we are all too often reading and hearing about cars being intentionally used...
BY BRIAN KLEPPER A challenge for health care purchasers is choosing vendors whose performance matches their cost and outcomes claims. A 2015 Mercer survey found...
By LYGEIA RICCARDI This is the second post in a series on digital health inspired by Aetna and Apple, whose developing partnership is poised to impact millions ...
By KIP SULLIVAN, JD Is it ethical for health policy researchers to claim that a Medicare ACO reduced “spending” by 2 percent if the reduction was not statistica...